1Ovemloyer BA. Chemotherapeutic palliative approaches in the treatment of breast cancer. Semi Oncol 1995; 22 (2 Suppl 3) : 2 - 9. 被引量：1
2Ferrell Br, Grant M, Funk Bet al. Quality of life in breast cancer. Cancer Pract.1996; 4 (6): 331- 340. 被引量：1
3Selby PJ, Champon JA, Etazadi- Amoli J, et al. The development of a method for assessing the quality of life of cancer patients. Br J Cancer 1984; 50 (1): 13-22. 被引量：1
4Blade MJ, Cella DF, Mo, F et al. Reliability and validity of the functional assessment of cancer therapy - Breast quality - of- life instrument.Journal of Clinical Oncology 1997; 15 (3): 974 -986. 被引量：1
5Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: Development and validation of the general measure.Journal of Clinical Oncology 1993; 11 (3) : 570 - 579. 被引量：1
6Aaronsen NK, Cull A, Kaasa S, et al. The European Organization for Research and Treatment of Cancer (EOPTC) modular approach to quality of life assessment in oncology. Int. J. Ment. Health 1994; 23 (2): 75-96. 被引量：1
7Sprangers MA.The European Organization for Research and Treatment of Cancer breast cancer- specific quality - of- life questionnaire module: first results from a three- country field study. J Clin Oncol. 1996; 14 (10) : 2756- 2768. 被引量：1
9Chachaj A,Malyszczak K,Pyszel K,et al. Physical and psychological im-pair-ments of women with upper limb lymphedema following breast can-cer treatment [J]. Psychooncology, 2010,19 (3):299-305. 被引量：1
10Smoot B, Wong J, Cooper B, et al. Upper extremity impairments inwomen with or without lymphedema following breast cancer treatment[J]. J Cancer Surviv,2010,4(2) ; 167-178. 被引量：1
